UAE approves use of new drug to treat vitiligo
The UAE has approved the use of a new drug to treat vitiligo. The drug, called Rinvok, is designed for the treatment of non-segmental vitiligo, for those aged over 12. The Emirates Drug Authority announced on Monday that the UAE was the first country in the world to adopt the drug. Vitiligo is a condition which causes loss of skin colour in patches. It causes the skin to lose its pigment cells,…
The United Arab Emirates has given the green light for the use of a novel drug to treat vitiligo. The medication, named Rinvok, is specifically formulated for the management of non-segmental vitiligo in individuals over the age of 12. The Emirates Drug Authority announced on Monday that the UAE became the first nation globally to approve this drug.
Vitiligo is a skin condition that leads to patches of loss of pigmentation, resulting in discolored spots on various body parts. There is currently no cure for this disorder, which affects between 0.5 and 1 percent of the global population. The UAE's swift adoption of Rinvok underscores its commitment to embracing cutting-edge pharmaceutical advancements and ensuring timely access to these innovations, according to a statement from the Emirates Drug Authority.
This approval is part of the country's robust regulatory framework that keeps abreast with global scientific progress and enhances the pharmaceutical sector's capabilities, ultimately improving patient treatment outcomes.
Written by urgent.news from The National UAE's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- UAE approves use of new drug to treat vitiligo thenationalnews.com
